About
Booster Therapeutics develops small molecule therapeutics that directly activate the 20S proteasome to restore natural protein degradation processes, aiming to treat degenerative diseases including neurodegenerative disorders associated with proteasome dysfunction.
Explore Booster Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.